Guillaume Monneret Selected Research

Guillaume Monneret Research Topics

Disease

65	Septic Shock (Toxic Shock Syndrome) 09/2022 - 09/2002
55	Sepsis (Septicemia) 03/2022 - 09/2004
16	Critical Illness (Critically Ill) 04/2022 - 01/2011
15	COVID-19 04/2022 - 01/2020
15	Infections 01/2022 - 06/2003
12	Cross Infection (Nosocomial Infection) 01/2018 - 01/2008
11	Shock 02/2021 - 11/2004
10	Wounds and Injuries (Trauma) 12/2021 - 12/2005
9	Lymphopenia (Lymphocytopenia) 04/2022 - 10/2012
7	Coinfection 01/2022 - 12/2005
5	Neoplasms (Cancer) 01/2022 - 02/2013
5	Burns 01/2018 - 08/2007
4	Asthma (Bronchial Asthma) 10/2018 - 01/2003
2	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 12/2021 - 10/2021
2	Ventilator-Associated Pneumonia 10/2021 - 01/2002
2	Pneumonia (Pneumonitis) 10/2021 - 01/2021
2	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 01/2020 - 11/2018
2	Out-of-Hospital Cardiac Arrest 01/2019 - 01/2016
2	Human Influenza (Influenza) 12/2018 - 01/2018
2	Communicable Diseases (Infectious Diseases) 12/2013 - 03/2013
2	Hypersensitivity (Allergy) 06/2005 - 02/2002
1	Necrotizing Fasciitis 09/2022
1	Superinfection 09/2022
1	B-Cell Lymphoma (Lymphoma, B Cell) 04/2022
1	Asymptomatic Infections 01/2021
1	Cytokine Release Syndrome 01/2021
1	Viremia 05/2019
1	Ischemia 01/2019
1	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 12/2018
1	Atopic Dermatitis (Atopic Eczema) 10/2018
1	Hyperlactatemia 02/2018
1	HIV Infections (HIV Infection) 01/2018

Drug/Important Bio-Agent (IBA)

28	HLA-DR Antigens (HLA-DR)IBA 04/2022 - 07/2003
27	Biomarkers (Surrogate Marker)IBA 01/2021 - 04/2009
18	HLA Antigens (Human Leukocyte Antigens)IBA 10/2021 - 07/2003
17	CytokinesIBA 01/2022 - 07/2004
17	Messenger RNA (mRNA)IBA 04/2019 - 11/2004
15	Interleukin-7 (Interleukin 7)IBA 04/2022 - 11/2012
11	Immunologic Adjuvants (Immunologic Adjuvant)IBA 04/2019 - 02/2013
9	Interleukin-10 (Interleukin 10)IBA 01/2021 - 09/2004
9	Proteins (Proteins, Gene)FDA Link 04/2019 - 01/2005
5	AntigensIBA 12/2019 - 09/2002
3	AutoantibodiesIBA 01/2022 - 01/2021
3	Immunoglobulins (Immunoglobulin)IBA 11/2021 - 12/2011
3	Indicators and Reagents (Reagents)IBA 01/2021 - 12/2004
3	AntibodiesIBA 01/2021 - 01/2018
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020 - 09/2004
3	alpha chain interleukin-7 receptorIBA 01/2019 - 11/2012
3	Antigen-Antibody Complex (Immune Complex)IBA 01/2019 - 01/2018
3	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2018 - 02/2013
3	Interferon-gamma (Interferon, gamma)IBA 03/2014 - 01/2011
2	InterferonsIBA 09/2022 - 10/2021
2	Immunoglobulin G (IgG)IBA 11/2021 - 12/2011
2	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2021 - 01/2015
2	Peptides (Polypeptides)IBA 01/2021 - 01/2005
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2021 - 01/2013
2	Retroelements (Retrotransposon)IBA 01/2020 - 07/2018
2	Lactic Acid (Lactate)FDA LinkGeneric 05/2019 - 02/2018
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2019 - 10/2014
2	N 30IBA 01/2018 - 11/2004
2	LipopolysaccharidesIBA 05/2017 - 01/2015
2	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2017 - 01/2015
2	Interleukin-7 Receptors (Interleukin 7 Receptor)IBA 08/2014 - 11/2012
2	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 12/2011 - 01/2005
2	Hormones (Hormone)IBA 12/2010 - 11/2009
2	Staphylococcal enterotoxin AIBA 09/2009 - 10/2006
2	Enterotoxins (Enterotoxin)IBA 09/2009 - 10/2006
2	Immunoglobulin E (IgE)IBA 06/2005 - 02/2002
2	ProcalcitoninIBA 03/2003 - 01/2002
1	NivolumabIBA 09/2022
1	LectinsIBA 01/2022
1	Biological ProductsIBA 01/2022
1	Oxidized LDL ReceptorsIBA 01/2022
1	Immunoglobulin M (IgM)IBA 11/2021
1	Dexamethasone (Maxidex)FDA LinkGeneric 10/2021
1	Sialic Acid Binding Immunoglobulin-like LectinsIBA 01/2021
1	Prednisolone (Predate)FDA LinkGeneric 01/2021
1	indolepropanol phosphate (IPP)IBA 01/2020
1	Nucleic AcidsIBA 05/2019
1	Antiviral Agents (Antivirals)IBA 12/2018
1	Zanamivir (Relenza)FDA Link 12/2018
1	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 12/2018
1	Betamethasone (Celestone)FDA Link 10/2018
1	compound 18IBA 10/2018
1	DinitrofluorobenzeneIBA 10/2018
1	OvalbuminIBA 10/2018
1	PTX3 proteinIBA 01/2018
1	Programmed Cell Death 1 ReceptorIBA 01/2018

Therapy/Procedure

22	Therapeutics 09/2022 - 09/2004
9	Immunotherapy 10/2020 - 01/2011
4	Length of Stay 12/2021 - 01/2015
2	Immunomodulation 03/2022 - 01/2018
2	Artificial Respiration (Mechanical Ventilation) 10/2021 - 05/2013
2	Hematopoietic Stem Cell Transplantation 01/2018 - 02/2016
2	Resuscitation 09/2008 - 01/2008
1	Transplantation 12/2018
1	Cell Transplantation 12/2018
1	Lung Transplantation 12/2018
1	Intravenous Administration 12/2018
1	Pneumonectomy (Lung Volume Reduction) 01/2018